E-merge Capital Partners (E-merge) announced today the first close of its venture fund (E-merge Fund I), which is based on early-stage medical technology companies and technologies. To the new company, the E-merge team brings decades of medical device and venture funding expertise, as well as a diverse set of entrepreneurial backgrounds. Managing Partners Brad Klos and John M. Xitco, as well as Venture Partners Randy Werneth and Rob Abrams, will lead the company.
Brad Klos, Managing Partner of E-merge Capital Partners, said, “Over the past few years, the MedTech industry has experienced significant growth and we see great opportunity to fund and support startups and introduce disruptive technologies to the marketplace. We have assembled a dedicated team of industry experts, physicians and seasoned investors to identify solutions that will deliver the best outcomes for patients and our portfolio companies.”The fund would consider investments in specific class I and class III medical devices, as well as medical specialties outside of cardiovascular and orthopaedics. This is only if innovations meet the firm’s rigorous de-risking requirements. E-partnership merge’s with Evolve MedTech Venture Studio provides a team of professional engineers to provide medical device technology with disciplined creation and design for manufacturing principles.
E-merge Capital Partners is a venture capital company dedicated to assisting entrepreneurs in the development of next-generation medical technology products and businesses. The company focuses on companies that are designing and researching new medical devices and innovations. E-merge has assembled a team with deep experience in finance, operations, and product growth, allowing for a hands-on approach to business development.E-merge Capital Partners (E-merge) announced today the first close of its venture fund (E-merge Fund I), which is based on early-stage medical technology companies and technologies. To the new company, the E-merge team brings decades of medical device and venture funding expertise, as well as a diverse set of entrepreneurial backgrounds. Managing Partners Brad Klos and John M. Xitco, as well as Venture Partners Randy Werneth and Rob Abrams, will lead the company.
The fund would consider investments in specific class I and class III medical devices, as well as medical specialties outside of cardiovascular and orthopaedics. This is only if innovations meet the firm’s rigorous de-risking requirements. E-partnership merge’s with Evolve MedTech Venture Studio provides a team of professional engineers to provide medical device technology with disciplined creation and design for manufacturing principles.E-merge Capital Partners is a venture capital company dedicated to assisting entrepreneurs in the development of next-generation medical technology products and businesses. The company focuses on companies that are designing and researching new medical devices and innovations. E-merge has assembled a team with deep experience in finance, operations, and product growth, allowing for a hands-on approach to business development.
Be First to Comment